Market Report, "MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts", Published

Recently published research from GlobalData, "MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts", is now available at Fast Market Research

Logo

Boston, MA -- (SBWire) -- 05/11/2013 --MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts

Summary

Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics' position in the market is dependent on it being the leading provider of the most common breast cancer mutations. By the end of our forecast period, the competitive landscape will experience significant change due to the erosion of Myriad Genetics' position, as a result of the expiry of key patents, and the emergence of alternative molecular technologies.

View Full Report Details and Table of Contents

This report focuses on the predictive breast cancer gene testing markets in Europe (France, Germany, Italy, Spain, and the UK), and identifies unmet needs in the market, physician attitudes towards current gene testing, and the future of gene testing in the face of rapid technological advancement.

Scope

- An overview of Breast Cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized EU Breast Cancer Gene Testing market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for Breast Cancer Gene Testing
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of EU device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as oncologists

Reasons to Get This Report

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts
- MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts
- MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts
- Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- MediPoint: Total Ankle Replacement - EU Analysis and Market Forecasts
- MediPoint: Bioabsorbable Stents - EU Analysis and Market Forecasts
- Breast Imaging Technologies Market - Technology and Market Analysis & Global Forecasts to 2017
- MediPoint: Total Wrist Reconstruction - EU Analysis and Market Forecasts
- MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets
- Qiagen N.V Market Share Analysis

Media Relations Contact

Bill Thompson
Director of Marketing
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/248808